Subscribe Us

header ads

Recents

header ads

Biobanking Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - January 31, 2023

According to the research report, the global biobanking market size is expected to touch USD 115.4 Billion by 2030, from USD 72.84 Billion in 2022, growing with a significant CAGR of 5.9% from 2022 to 2030.

Biobanking Market Size 2022 to 2030

The biobanking report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global biobanking in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global biobanking market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global biobanking during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1641

 Report Scope of the Biobanking Market

Report CoverageDetails
Market Size by 2030USD 115.4 Billion
Growth Rate from 2022 to 2030

CAGR of 5.9%

Europe Market Share in 202135%
Physical Biobanks Market Share in 202180%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredProduct, Service, Biospecimen Type, Biobank, Application, Type of Biobank, Ownership, Storage, Region

This study covers a detailed segmentation of the global biobanking market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global biobanking market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Brooks Life Sciences
  • TTP Labtech
  • VWR International, LLC.
  • Promega Corporation
  • Worthington Industries
  • BD
  • Merck KGaA
  • Biokryo GmbH
  • Cell&Co BioServices
  • RUCDR Infinite Biologics
  • Modul-Bio

Market Segmentation

 By Product

  • Equipment
  • Consumables
  • Laboratory Information Systems

By Service

  • Biobanking and Repository
  • Validation/Qualification
  • Lab Processing
  • Cold Chain Logistic
  • Others

By Biospecimen Type

  • Human Tissues
  • Stem Cells
  • Organs
  • Others

By Biobank

  • Physical Biobanks
  • Virtual Biobanks

By Application

  • Drug Discovery and Clinical Research
  • Therapeutics
  • Clinical Diagnostics
  • Others

By Type of Biobank

  • Population-based Biobanks
  • Disease-oriented Biobanks

By Ownership

  • National/regional agency
  • Non-Profit Organization
  • Universities
  • Private Organization

By Storage

  • Manual Storage
  • Automated Storage

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global biobanking report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global biobanking market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Biobanking Market, By Service

7.1. Biobanking Market, by Service, 2021-2030

7.1.1. Biobanking and Repository

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Validation/Qualification

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Lab Processing

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Cold Chain Logistic

7.1.4.1. Market Revenue and Forecast (2017-2030)

7.1.5. Other

7.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Biobanking Market, By Product

8.1. Biobanking Market, by Product, 2021-2030

8.1.1. Equipment

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Laboratory Information Systems

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Biobanking Market, By Biospecimen

9.1. Biobanking Market, by Biospecimen, 2021-2030

9.1.1. Human Tissues

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Stem Cells

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Organs

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Biobanking Market, By Biobank

10.1. Biobanking Market, by Biobank, 2021-2030

10.1.1. Physical Biobanks

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Virtual Biobanks

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Biobanking Market, By End-use

11.1. Biobanking Market, by End-use, 2021-2030

11.1.1. Drug Discovery and Clinical Research

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Therapeutics

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Clinical Diagnostics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Biobanking Market, By Type of Biobank

12.1. Biobanking Market, by Type of Biobank, 2021-2030

12.1.1. Population-based Biobanks

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Disease-oriented Biobanks

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Biobanking Market, By Ownership

13.1. Biobanking Market, by Ownership, 2021-2030

13.1.1. National/regional agency

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Non-Profit Organization

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Universities

13.1.3.1. Market Revenue and Forecast (2017-2030)

13.1.4. Private Organization

13.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Biobanking Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Service (2017-2030)

14.1.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.1.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.1.5. Market Revenue and Forecast, by End-use (2017-2030)

14.1.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.1.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.1.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.1.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.1.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.1.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.1.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.1.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.1.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.1.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2. Europe

14.2.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.10.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.10.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.10.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.10.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.10.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.10.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.11.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.11.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.11.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.11.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.10.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.10.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.10.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.11.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.11.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.11.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.11.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.11.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.10.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.10.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.10.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.11.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.11.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.11.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.11.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.11.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Service (2017-2030)

14.5.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.5.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.5.5. Market Revenue and Forecast, by End-use (2017-2030)

14.5.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.5.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.5.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.5.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.5.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.5.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.5.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.5.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.5.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

Chapter 15. Company Profiles

15.1. Thermo Fisher Scientific Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Tecan Trading AG

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. QIAGEN

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Hamilton Company

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Brooks Life Sciences

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. TTP Labtech

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. VWR International, LLC.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Promega Corporation

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Worthington Industries

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. BD

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

15.11. Merck KGaA

15.11.1. Company Overview

15.11.2. Product Offerings

15.11.3. Financial Performance

15.11.4. Recent Initiatives

15.12. Biokryo GmbH

15.12.1. Company Overview

15.12.2. Product Offerings

15.12.3. Financial Performance

15.12.4. Recent Initiatives

15.13. Cell&Co BioServices

15.13.1. Company Overview

15.13.2. Product Offerings

15.13.3. Financial Performance

15.13.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments